Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA

Kari Majamaa1,2, Mikko Kärppä1,2, Jukka S Moilanen3,4

  • 1Research Unit of Clinical Medicine, Neurology, University of Oulu, Oulu, Finland.

BMJ Neurology Open
|September 26, 2024
PubMed
Abstract

Insights

The common m.3243A>G mitochondrial DNA variant causes varied adult symptoms, with hearing loss, cognitive decline, and myopathy being frequent. Stroke-like episodes are rare, but severity is influenced by heteroplasmy, age, and sex.

Area of Science:

  • Genetics
  • Neurology
  • Mitochondrial Diseases

Background:

  • The m.3243A>G variant in mitochondrial DNA (mtDNA) is a primary cause of MELAS syndrome.
  • In adults, this variant presents with diverse neurological symptoms, often without the classic MELAS phenotype.

Purpose of the Study:

  • To determine the frequency of clinical phenotypes in adults with the m.3243A>G mtDNA variant.
  • To analyze factors influencing phenotype presentation, including heteroplasmy, age, sex, and mtDNA haplogroup.

Main Methods:

  • Clinical examination of 51 adult patients with the m.3243A>G variant.
  • Meta-analysis of 25 published case series (1314 patients) to assess neurological feature frequencies.

Main Results:

  • Sensorineural hearing impairment, cognitive impairment, and myopathy were the most prevalent manifestations.
  • Stroke-like episodes were infrequent; heteroplasmy and age modestly predicted phenotypes, with progression over time.
  • Male sex correlated with increased disability, while haplogroup UK showed no significant association.

Conclusions:

  • Adults with m.3243A>G commonly exhibit sensorineural hearing loss, cognitive impairment, and myopathy, with stroke-like episodes being rare.
  • Mitochondrial DNA heteroplasmy, age, sex, and haplogroup significantly contribute to disease severity and phenotype expression.
  • Meta-analysis offers a reliable estimation of neurological symptoms in adults carrying the m.3243A>G variant.